The rising tide: Skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus

Southern Medical Journal

Volumn 102, Issue 2, 2009, Pages 121-122

  Stevens, Michael P ^a,b   Edmond, Michael B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; BACTERIAL TRANSMISSION; COMPARATIVE STUDY; EDITORIAL; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR TYPING; PHENOTYPE; PREVALENCE; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; COMMUNICABLE DISEASE; MICROBIOLOGY; NOTE; RISK FACTOR; STAPHYLOCOCCAL SKIN INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 63249101549     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318181811b     Document Type: Editorial

References (9)

1. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436 -1444.
2. Gorwitz RJ. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2008;27:1-7.
3. Deurenberg RH, Vink C, Kalenic S, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007; 13:222-235.
4. Le J, Lieberman JM. Management of community-associated methicillinresistant Staphylococcus aureus infections in children. Pharmacotherapy 2006;26:1758 -1770.
5. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-674.
6. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785-1791.
7. Furuya EY, Cook HA, Lee MH, et al. Community-associated methicillinresistant Staphlococcus aureus prevalence: how common is it? A methodological comparison of prevalence ascertainment. Am J Infect Control 2007;35:359 -366.
8. Tejeda-Ramirez E, Behani M, Leggiadro RJ. Community-associated methicillin-resistant staphylococcal infection in an inner city hospital pediatric inpatient population. South Med J 2009;102:135-138.
9. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillinresistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044-4048.